SECsense Logo

Medtronic plc Financial Report: Key Insights on Stock & Senior Notes (2025)

$MDT
Form 8-K
Filed on: 2025-03-17
Source
Medtronic plc Financial Report: Key Insights on Stock & Senior Notes (2025)

The provided section of the financial report contains several key pieces of information regarding Medtronic plc, particularly related to its stock and senior notes. Here are the most important insights extracted from the data:

  1. Company Information:
  • Entity Identifier: Medtronic plc CIK number is 0001613103.
  • Company Address: Building Two, Parkmore Business Park West, Galway, Ireland. Contact number: +353 1 438 1700.
  1. Reporting Period:
  • Start and End Date: The financial data pertains to the period beginning and ending on March 12, 2025.
  1. Stock Information:
  • Ordinary Shares: The par value of the ordinary shares is $0.0001 per share, trading under the symbol MDT on the NYSE.
  1. Senior Notes:
  • Medtronic has issued multiple series of senior notes with varying interest rates and due dates. The key details include:
    • 0.250% Senior Notes due 2025 (MDT/25)
    • 0.000% Senior Notes due 2025 (MDT/25A)
    • 2.625% Senior Notes due 2025 (MDT/25B)
    • 1.125% Senior Notes due 2027 (MDT/27)
    • 0.375% Senior Notes due 2028 (MDT/28)
    • 3.000% Senior Notes due 2028 (MDT/28A)
    • 3.650% Senior Notes due 2029 (MDT/29)
    • 1.625% Senior Notes due 2031 (MDT/31)
    • 1.000% Senior Notes due 2031 (MDT/31A)
    • 3.125% Senior Notes due 2031 (MDT/31B)
    • 0.750% Senior Notes due 2032 (MDT/32)
    • 3.375% Senior Notes due 2034 (MDT/34)
    • 3.875% Senior Notes due 2036 (MDT/36)
    • 2.250% Senior Notes due 2039 (MDT/39A)
    • 1.500% Senior Notes due 2039 (MDT/39B)
    • 1.375% Senior Notes due 2040 (MDT/40A)
    • 4.150% Senior Notes due 2043 (MDT/43A)
    • 1.750% Senior Notes due 2049 (MDT/49)
    • 1.625% Senior Notes due 2050 (MDT/50)
    • 4.150% Senior Notes due 2053 (MDT/53)
  1. Trading Symbols:
  • Each series of senior notes has a corresponding trading symbol listed for investors to track.

The report indicates a diverse range of financing options through senior notes, which may affect the company's capital structure and interest obligations in the coming years. The low-interest rates on some of the notes suggest Medtronic is managing its debt effectively, potentially allowing for lower financing costs.